AROS PHARMA ApS: Financial statements 2013
CVR: 32102816
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
AROS PHARMA ApS (CVR 32102816) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -3,900,963 compared with DKK -3,245,679 the year before. Equity in the 2013 report amounted to DKK 255,158. The solvency ratio was 5.5%.
- Profit/Loss
- DKK -3,900,963
- Equity
- DKK 255,158
- Total Assets
- DKK 4,622,151
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | -3.9 mio. | 255 t. | - |
| 2012 | - | - | -3.2 mio. | 4.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
AROS PHARMA ApS has published its annual report for 2012. The net result was DKK -3,245,679.
As of April 5, 2013, Line Holten Reimer has joined the board of directors of AROS PHARMA ApS.
As of April 5, 2013, Ole Bitsch-Jensen has left the board of directors of AROS PHARMA ApS.
About AROS PHARMA ApS
AROS PHARMA ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2009. The company has been dissolved on 14 October 2016. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees (2015). In 2015, the company reported a net result of DKK -721,837 compared with DKK -2,904,493 the year before. Equity in the 2015 report amounted to DKK -3,371,172.